N/A
N=907
HMO Research Network CERT: Acute Myocardial Infarction
Acute Myocardial Infarction (AMI)
Bottom Line
View on ClinicalTrials.gov: NCT00211172 ↗Enrolled (actual)
907
Serious AEs
—
Results posted
Oct 2014
Primary outcome: Primary: Adjusted Mean Monthly Percent of Days Covered With B-blocker Following Intervention Date — 66.37; 70.62 Adjusted monthly % of days covered
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Beta-blocker adherence after an AMI (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Kaiser Permanente
- Primary completion
- Dec 2005
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adjusted Mean Monthly Percent of Days Covered With B-blocker Following Intervention Date |
66.37; 70.62 | — |
Summary
The primary goal of this study is to evaluate the effectiveness of direct-to-patient mailings designed to increase patient's adherence to prescribed beta-blockers following an acute myocardial infarction (AMI).
Prior to developing patient materials, focus groups were conducted with patient who had previously suffered an acute myocardial infarction (AMI) to identify the issues and information that patients felt were important to include in our materials as well as the best way to present the information. Additionally, patient materials were "pre-tested" with AMI patients to ensure that the materials were clear and easy to read and that the key messages were understood.
Eligibility Criteria
Inclusion Criteria
- Clinical diagnosis of Acute Myocardial Infarction (AMI) from 12/1/03 to 5/31/04
- Beta-blocker dispensing following AMI
- Beta-blocker dispensing prior to intervention date
Exclusion Criteria
None
Data sourced from ClinicalTrials.gov (NCT00211172). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.